The PRIAMO study: background, methods and recruitment.
PRIAMO (PaRkinson And non Motor symptOms) is an epidemiology study aimed to assess the prevalence and incidence of non-motor symptoms (NMS) in patients with parkinsonism. PRIAMO consists of two phases: (1) a transversal assessment of the prevalence of NMS and (2) a longitudinal observation with two follow-up visits at 12 and 24 months to establish the incidence of NMS. A secondary aim of PRIAMO is to study the relationship between NMS and quality of life. Patients with parkinsonism have been evaluated in 59 Neurology Centres widely distributed throughout Italy. PRIAMO has analysed a total of 1307 patients (out of 1325 initially enrolled). We expect that PRIAMO will substantially help to quantify the burden of NMS in patients with parkinsonism.
Antonini
Angelo
A
Parkinson Institute, Milan, Italy.
Colosimo
Carlo
C
Marconi
Roberto
R
Morgante
Letterio
L
Barone
Paolo
P
D000368:Aged; D001342:Autonomic Nervous System Diseases / Q000453:epidemiology; D015331:Cohort Studies; D015897:Comorbidity; D003430:Cross-Sectional Studies; D015340:Epidemiologic Research Design; D016021:Epidemiologic Studies; D005260:Female; D006801:Humans; D015994:Incidence; D007558:Italy / Q000453:epidemiology; D008137:Longitudinal Studies; D008297:Male; D019965:Neurocognitive Disorders / Q000453:epidemiology; D020734:Parkinsonian Disorders / Q000453:epidemiology*; D018579:Patient Selection; D015995:Prevalence; D011788:Quality of Life; D012893:Sleep Wake Disorders / Q000453:epidemiology